Literature DB >> 22298310

Disparities in access to care at high-volume institutions for uro-oncologic procedures.

Quoc-Dien Trinh1, Maxine Sun, Jesse Sammon, Marco Bianchi, Shyam Sukumar, Khurshid R Ghani, Wooju Jeong, Ali Dabaja, Shahrokh F Shariat, Paul Perrotte, Piyush K Agarwal, Craig G Rogers, James O Peabody, Mani Menon, Pierre I Karakiewicz.   

Abstract

BACKGROUND: Socioeconomic status represents an established barrier to health care access. Age, sex, and race may also play a role. The authors examined whether these affect the access to high-volume hospitals for uro-oncologic procedures in the United States.
METHODS: Within the Nationwide Inpatient Sample (NIS), the authors focused on radical prostatectomy (RP), radical cystectomy, and nephrectomy (Nx) performed within the 5 most contemporary years (2003-2007). Logistic regression models were used to estimate the impact of the primary predictors on the likelihood of receiving care at a high-volume hospital.
RESULTS: Between 2003 and 2007, 62,165 RP, 6557 radical cystectomy, and 28,062 Nx cases were recorded within the NIS. Patient age (P = .001), year of surgery (P = .001), Charlson Comorbidity Index (P ≤ .025), median Zip Code income (highest vs lowest quartile, P = .001), and insurance status (private vs Medicare, P = .008) were independent predictors of being treated at high-volume institutions. Moreover, black race was an independent predictor of decreased utilization of high-volume institutions for radical cystectomy (P = .012), and female sex was an independent predictor of decreased utilization of high-volume institutions for Nx (P = .016).
CONCLUSIONS: On average, old, sick, poor, and Medicare patients were less likely to be treated at high-volume hospitals for uro-oncologic surgery. Similarly, black patients were less likely to have a radical cystectomy at a high-volume hospital, and female patients were less likely to have an Nx at a high-volume hospital. Selective referral of individuals who are less likely to receive care at such institutions may represent a health care priority intended to optimize outcomes across all population strata.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Year:  2012        PMID: 22298310     DOI: 10.1002/cncr.27440

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  25 in total

1.  Persisting Racial Disparities in Total Shoulder Arthroplasty Utilization and Outcomes.

Authors:  Jasvinder A Singh; Rekha Ramachandran
Journal:  J Racial Ethn Health Disparities       Date:  2015

2.  Multimorbidity and access to major cancer surgery at high-volume hospitals in a regionalized era.

Authors:  Chukwuemeka Ihemelandu; Chaoyi Zheng; Erin Hall; Russell C Langan; Nawar Shara; Lynt Johnson; Waddah Al-Refaie
Journal:  Am J Surg       Date:  2016-02-28       Impact factor: 2.565

3.  Association between hospital case volume and the use of bronchoscopy and esophagoscopy during head and neck cancer diagnostic evaluation.

Authors:  Gordon H Sun; Oluseyi Aliu; Nicholas M Moloci; Joshua K Mondschein; James F Burke; Rodney A Hayward
Journal:  Cancer       Date:  2013-09-24       Impact factor: 6.860

4.  Racial disparities in operative outcomes after major cancer surgery in the United States.

Authors:  Shyam Sukumar; Praful Ravi; Akshay Sood; Mai-Kim Gervais; Jim C Hu; Simon P Kim; Mani Menon; Florian Roghmann; Jesse D Sammon; Maxine Sun; Vincent Q Trinh; Quoc-Dien Trinh
Journal:  World J Surg       Date:  2015-03       Impact factor: 3.352

5.  Regional trends in average years of potential life lost (AYPLL) secondary to prostate cancer deaths among Caucasians and African Americans treated by surgery or radiation.

Authors:  Mohamed H Kamel; Milan Bimali; Mahmoud I Khalil; Ehab Eltahawy; LJoseph Su; Nabil K Bissada; Rodney Davis
Journal:  Int Urol Nephrol       Date:  2019-03-06       Impact factor: 2.370

Review 6.  Diffusion of robotics into clinical practice in the United States: process, patient safety, learning curves, and the public health.

Authors:  Hossein S Mirheydar; J Kellogg Parsons
Journal:  World J Urol       Date:  2012-12-29       Impact factor: 4.226

7.  Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia.

Authors:  Florian R Schroeck; John M Hollingsworth; Brent K Hollenbeck; Bruce L Jacobs; Anne M Suskind; Aruna V Sarma; John T Wei
Journal:  Urology       Date:  2013-03-19       Impact factor: 2.649

Review 8.  Racial and gender disparities among patients with gout.

Authors:  Jasvinder A Singh
Journal:  Curr Rheumatol Rep       Date:  2013-02       Impact factor: 4.592

9.  Robotic-assisted simple prostatectomy versus open simple prostatectomy: a New York statewide analysis of early adoption and outcomes between 2009 and 2017.

Authors:  Krishna T Ravivarapu; Olamide Omidele; John Pfail; Nir Tomer; Alexander C Small; Michael A Palese
Journal:  J Robot Surg       Date:  2020-10-03

10.  Receipt of best care according to current quality of care measures and outcomes in men with prostate cancer.

Authors:  Florian R Schroeck; Samuel R Kaufman; Bruce L Jacobs; Brent K Hollenbeck
Journal:  J Urol       Date:  2014-08-07       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.